LGND
LGND
NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$293.15
-6.99 (-2.33%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -89.2% upside
Low Target $18.80
Average Target $31.56
High Target $35.41
Current Price $293.15
Current
$293.15
Target
$31.56
$18.80 $31.56 avg $35.41
Scenario Analysis
Bear Case
$18.80
-93.6%
Low target
Base Case
$31.56
-89.2%
Avg target
Bull Case
$35.41
+-87.9%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$326.63
-10.3% from high
52-Week Low
$132.21
+121.7% from low
50-Day SMA
$193.47
+51.5% vs SMA
200-Day SMA
$162.08
+80.9% vs SMA
RSI (14)
38.7
Neutral
Target vs 52W High
$31.56
-90.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%